About

Eugene Rogers is an associate professor of music and the director of university choirs at the University of Michigan School of Music, Theatre & Dance. He is recognized as a leading conductor and pedagogue throughout the United States and abroad, with notable achievements including being a two-time Michigan Emmy Award winner, a 2017 Sphinx Medal of Excellence recipient, and a 2015 GRAMMY® Award nominee. Rogers is the founding director of EXIGENCE and currently leads the graduate choral conducting program, conducts the chamber choir, and administers over eight choral ensembles at the university. His choirs have toured internationally to China, South Africa, and across the United States, and have appeared at national and regional conferences. In December 2017, Musical America named him one of the top 30 “Movers and Shapers” professionals in North America. Rogers has held previous appointments including director of the University of Michigan Men’s Glee Club, positions at Macalester College, the Boys Choir of Harlem, Waubonsie Valley High School, and Anima Young Singers of Greater Chicago. His work emphasizes social justice issues in music, as highlighted in the documentary Love, Life and Loss, and he has contributed to collaborative projects such as the joint CD Ye Shall Have a Song with the Michigan, Yale, and Harvard Glee Clubs. Rogers holds a Bachelor of Arts degree in choral music education from the University of Illinois at Urbana-Champaign, and both a Master of Music and Doctor of Musical Arts degrees in choral conducting from the University of Michigan. He currently serves on the board of Chorus America and has been involved in initiatives promoting diversity within choral music.

Research topics

• Medicine
• Intensive care medicine
• Internal medicine
• Nursing
• Emergency medicine

Selected publications

• RISK OF ADVERSE OUTCOMES ASSOCIATED WITH INITIAL CLINICAL PRESENTATION OF CARDIAC SARCOIDOSIS

  Journal of the American College of Cardiology · 2025-03-29

  articleOpen access
  PublisherDOI

• Association of Screen Time Activities with Lifestyle Behaviors in Middle-School Children

  Pediatric Cardiology · 2025-04-19

  article
  PublisherDOI

• Outcomes of direct oral anticoagulants with aspirin vs warfarin with aspirin: a registry-based cohort study

  Research and Practice in Thrombosis and Haemostasis · 2024-05-01 · 3 citations

  articleOpen access

  Background: For patients anticoagulated with direct oral anticoagulants (DOACs) or warfarin and on aspirin (ASA) for nonvalvular atrial fibrillation and/or venous thromboembolism, it is unclear if bleeding outcomes differ. Objectives: To assess bleeding rates for ASA with DOACs vs warfarin and one another. Methods: Registry-based cohort study of patients followed by a 6-center quality improvement collaborative in Michigan using data from 2009 to 2022. The study included adults on ASA with warfarin or DOACs for atrial fibrillation and/or venous thromboembolism without a recent myocardial infarction or heart valve replacement. Results: After propensity matching by anticoagulant class, we compared 2 groups of 1467 patients followed for a median of 18.0 months. Any bleeding and nonmajor bleeding was increased with DOACs + ASA compared with warfarin + ASA (32.2 vs 27.8 and 27.1 vs 22.9 events/100 patient-years; relative risks [RRs], 1.1 and 1.2; 95% CIs, 1.1-1.2 and 1.1-1.3, respectively). After matching by drug, patients on apixaban + ASA vs warfarin + ASA had more bleeding (31.2 vs 27.8 events/100 patient-years; RR, 1.1; 95% CI, 1.0-1.2) and nonmajor bleeding but less major bleeding (3.8 vs 4.7 events/100 patient-years; RR, 0.8; 95% CI, 0.6-1.0) and emergency room visits for bleeding. Patients on rivaroxaban + ASA vs warfarin + ASA had more bleeding (39.3 vs 26.3 events/100 patient-years, RR, 1.5; 95% CI, 1.3-1.6), nonmajor bleeding, and thrombosis. Patients on apixaban + ASA vs rivaroxaban + ASA had significantly less bleeding (22.5 vs 39.3/100 patient-years; RR, 0.6; 95% CI, 0.5-0.7), nonmajor bleeding, major bleeding (2.1 vs 5.5 events/100 patient-years; RR, 0.4; 95% CI, 0.2-0.6), emergency room visits for bleeding, and thrombotic events. Conclusion: Patients on DOAC + ASA without a recent myocardial infarction or heart valve replacement had more nonmajor bleeding but otherwise similar outcomes compared with warfarin + ASA. Patients treated with rivaroxaban + ASA experienced more adverse clinical events compared with warfarin + ASA or apixaban + ASA.

  PublisherDOI

• Associations Between Perceived Parental and Michigan Middle-School Students’ Lifestyle Characteristics

  American Journal of Lifestyle Medicine · 2024-08-16 · 1 citations

  articleOpen access

  BACKGROUND: Parents play a critical role in their children's health. We explored the association of children's perception of their parents' health behaviors and education level with the health behaviors of middle-school students participating in a school-based wellness program. METHODS: Students completed a baseline survey on their dietary, physical activity, and sedentary behaviors, and their parents' health behaviors and education. Descriptive statistics and generalized linear regression with random intercept analyzed which child-reported parent behaviors, parent education levels, and demographic factors were associated with healthy child behaviors. RESULTS: Among 4607 students, for all behaviors assessed, children who perceived their parent exhibiting a healthy behavior were more likely to display the same healthy behavior. Healthier diet, more physical activity, and less sedentary habits were reported by students who reported their parents had college or higher education, compared to students who reported their parents had some college or less education. CONCLUSIONS: These results encourage increased parental involvement in childhood wellness programs. Additionally, these data suggest interventions which target parents with lower educational attainment may also benefit their children's health behaviors. As we continue to understand how adolescent behavior is shaped, we can increase the effectiveness of targeted health education for parents and children.

  PublisherOA PDFDOI

• Change in Cardiometabolic Health Following Participation in Cardiac Rehabilitation for Coronary Heart Disease: Effect Modification by Metabolic Syndrome Status

  Diabetes Metabolic Syndrome and Obesity · 2024-11-01

  articleOpen access

  Objective: To investigate changes in cardiometabolic risk factors after completion of cardiac rehabilitation (CR) for coronary heart disease (CHD) and ascertain whether the magnitude of improvement in cardiometabolic health differs between those with and without metabolic syndrome (MetS). Methods: In this observational cohort study, data were analyzed from 1984 patients enrolled in CR at the University of Michigan between 2011-01-01 and 2020-02-29 for the indication of CHD. Patient characteristics were collected from standardized health questionnaires and during CR intake evaluations. Cardiometabolic biomarkers were recorded from baseline laboratory data and re-examined upon completion of CR. Differences in baseline patient characteristics by MetS status were compared using chi-square tests. Wilcoxon rank-sum tests were used to compare baseline differences, and signed-rank tests were used to evaluate the change in variables between baseline and completion of CR. The difference of change by MetS status was assessed using difference-in-differences regression models. Results: Of the 1984 patients, 1070 (53.9%) met the criteria for MetS at baseline, of which 770 were male (72.0%). Those with MetS lost 1.43 pounds more (95% CI: 0.56, 2.31, P = 0.001), experienced a 0.21 larger drop in body mass index (95% CI: 0.03, 0.37, P = 0.02), and had a 0.31 greater reduction in waist circumference (95% CI: 0.08, 0.54, P = 0.008). Difference-in-differences regression models revealed those with MetS experienced a greater reduction in triglycerides and fasting glucose, with a difference of change of − 8.70 for triglycerides (95% CI: − 15.04, − 2.37, P = 0.007) and − 5.48 for glucose (95% CI: − 10.44, − 0.53, P = 0.03). There was no significant difference in the change in HDL-C or LDL-C for MetS status. Conclusion: Compared to those without MetS, patients with MetS experienced a comparable or greater benefit from CR, particularly with respect to improvements in MetS components. Keywords: chronic disease management, coronary heart disease, cardiometabolic risk factors, cardiovascular disease

  PublisherOA PDFDOI

• Direct Oral Anticoagulants in Obese Patients with Venous Thromboembolism: Results of an Expert Consensus Panel

  The American Journal of Medicine · 2023-02-16 · 23 citations

  review
  PublisherDOI

• Educational Attainment and Cardiovascular Risk Among Patients in Cardiac Rehabilitation

  The American Journal of Cardiology · 2023-10-07 · 3 citations

  article
  PublisherDOI

• Identifying Factors for Low-Risk Participation in Alternative Cardiac Rehabilitation Models for Patients with Coronary Heart Disease Using MI’S SCOREPAD

  Cardiovascular Therapeutics · 2023-09-08 · 2 citations

  reviewOpen access

  Introduction: Although a recent joint society scientific statement (the American Association of Cardiovascular Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology) suggests home-based cardiac rehab (CR) is appropriate for low- and moderate-risk patients, there are no paradigms to define such individuals with coronary heart disease. Methods: We reviewed a decade of data from all patients with coronary heart disease enrolled in a single CR center (University of Michigan) to identify the prevalence of low-risk factors, which may inform on consideration for participation in alternative models of CR. Low-risk factors included not having any of the following: metabolic syndrome, presence of implantable cardioverter defibrillator or permanent pacemaker, active smoking, prior stroke, congestive heart failure, obesity, advanced renal disease, poor exercise capacity, peripheral arterial disease, angina, or clinical depression (MI'S SCOREPAD). We report on the proportion of participants with these risk factors and the proportion with all of these low-risk factors. Results: = 0.08). Additionally, 9.3% of the 2011-2012 cohort and 7.6% of the 2018-2019 cohort had all 11 of the low-risk factors. Conclusion: In this observational study, we provide a first paradigm of identifying factors among coronary heart disease patients that may be considered low-risk and likely high-gain for participation in alternative models of CR. Further work is needed to track clinical outcomes in patients with these factors to determine thresholds for enrolling participants in alternative forms of CR.

  PublisherOA PDFDOI

• Twenty-five years of observations from the International Registry of Acute Aortic Dissection (IRAD) and its impact on the cardiovascular scientific community

  Journal of Thoracic and Cardiovascular Surgery · 2023-07-13 · 16 citations

  articleOpen access
  PublisherOA PDFDOI

• Cardiometabolic Risk and Dietary Behaviors in Middle-School Children Consuming School-Sourced Lunch

  Academic Pediatrics · 2023-08-03 · 3 citations

  articleOpen access
  PublisherOA PDFDOI

Frequent coauthors

• Kim A. Eagle

  University of Michigan–Ann Arbor

  498 shared

• James B. Froehlich

  Michigan Medicine

  211 shared

• Mauro Moscucci

  United States Food and Drug Administration

  167 shared

• Xiaokui Gu

  University of Michigan–Ann Arbor

  165 shared

• David Share

  Blue Cross Blue Shield of Michigan Foundation

  149 shared

• Ann Maxwell-Eward

  Trinity Health Oakland Hospital

  135 shared

• Kirit Patel

  Trinity Health

  134 shared

• John G. McGinnity

  Vivus (United States)

  134 shared

Education

• MS, RN, NP, Internal Medicine, Cardiology

  University of Michigan Hospital

Awards & honors

• 2017 Sphinx Medal of Excellence
• 2015 GRAMMY® Award nominee
• Two-time Michigan Emmy Award winner
• Named as the fifth Artistic Director of The Washington Choru…
• December 2017: Named one of the top 30 “Movers and Shapers”…